Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors

Fattizzo, B; Rampi, N; Barcellini, W

Fattizzo, B (通讯作者),Fdn IRCCS Ca Granda Osped Maggiore Policlin, I-20122 Milan, Italy.;Fattizzo, B (通讯作者),Univ Milan, Dept Oncol & Hematooncol, I-20122 Milan, Italy.

PHARMACEUTICALS, 2022; 15 (5):

Abstract

Checkpoint inhibitors (CPI) represent a novel therapeutical strategy with a high efficacy both in solid and hematological cancers. They act by reactiv......

Full Text Link